Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Mumps - Pipeline Review, H1 2015

Published: Jan-2015 | Format: PDF | Global Markets Direct | Number of pages: 39 | Code: MRS - 18126


Global Markets Directs, Mumps Pipeline Review, H1 2015, provides an overview of the Mumpss therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Mumps, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Mumps and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

The report provides a snapshot of the global therapeutic landscape of Mumps
The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
The report reviews key players involved in the therapeutics development for Mumps and enlists all their major and minor projects
The report summarizes all the dormant and discontinued pipeline projects 
A review of the Mumps products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
A detailed assessment of monotherapy and combination therapy pipeline projects
Coverage of the Mumps pipeline on the basis of target, MoA, route of administration and molecule type
Latest news and deals relating related to pipeline products

Reasons to buy

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop strategic initiatives by understanding the focus areas of leading companies
Identify and understand important and diverse types of therapeutics under development for Mumps
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Devise corrective measures for pipeline projects by understanding Mumps pipeline depth and focus of Indication therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table Of Content

Table of Contents 2
List of Tables 4
List of Figures 4

Introduction 5
Global Markets Direct Report Coverage 5
Mumps Overview 6
Therapeutics Development 7
Pipeline Products for Mumps - Overview 7
Pipeline Products for Mumps - Comparative Analysis 8
Mumps - Therapeutics under Development by Companies 9
Mumps - Therapeutics under Investigation by Universities/Institutes 10
Mumps - Pipeline Products Glance 11
Late Stage Products 11
Clinical Stage Products 12
Early Stage Products 13
Mumps - Products under Development by Companies 14
Mumps - Products under Investigation by Universities/Institutes 15
Mumps - Companies Involved in Therapeutics Development 16
Beijing Tiantan Biological Products Co., Ltd. 16
China National Pharmaceutical Group Corporation 17
GlaxoSmithKline plc 18
Prometheon Pharma, LLC 19
Zydus Cadila Healthcare Limited 20
Mumps - Therapeutics Assessment 21
Assessment by Monotherapy Products 21
Assessment by Combination Products 22
Assessment by Route of Administration 23
Assessment by Molecule Type 25
Drug Profiles 27
(measles [schwarz strain] + mumps [RIT 4385 strain] + rubella [wistar RA 27/3 strain])vaccine - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Cell Therapy for Measles, Mumps and Rubella - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
measles + mumps + rubella + varicella vaccine - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
measles + mumps + rubella + varicella vaccine - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
measles + mumps + rubella vaccine - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
measles + mumps + rubella vaccine - Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
mumps vaccine - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Mumps - Recent Pipeline Updates 34
Mumps - Dormant Projects 35
Mumps - Product Development Milestones 36
Featured News & Press Releases 36
Jun 13, 2012: UGA researcher developing new vaccine to fight resurging mumps virus 36

Appendix 38
Methodology 38
Coverage 38
Secondary Research 38
Primary Research 38
Expert Panel Validation 38
Contact Us 38
Disclaimer 39

List of Tables

Number of Products under Development for Mumps, H1 2015 7
Number of Products under Development for Mumps - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Number of Products under Investigation by Universities/Institutes, H1 2015 10
Comparative Analysis by Late Stage Development, H1 2015 11
Comparative Analysis by Clinical Stage Development, H1 2015 12
Comparative Analysis by Early Stage Development, H1 2015 13
Products under Development by Companies, H1 2015 14
Products under Investigation by Universities/Institutes, H1 2015 15
Mumps - Pipeline by Beijing Tiantan Biological Products Co., Ltd., H1 2015 16
Mumps - Pipeline by China National Pharmaceutical Group Corporation, H1 2015 17
Mumps - Pipeline by GlaxoSmithKline plc, H1 2015 18
Mumps - Pipeline by Prometheon Pharma, LLC, H1 2015 19
Mumps - Pipeline by Zydus Cadila Healthcare Limited, H1 2015 20
Assessment by Monotherapy Products, H1 2015 21
Assessment by Combination Products, H1 2015 22
Number of Products by Stage and Route of Administration, H1 2015 24
Number of Products by Stage and Molecule Type, H1 2015 26
Mumps Therapeutics - Recent Pipeline Updates, H1 2015 34
Mumps - Dormant Projects, H1 2015 35

List of Figures

Number of Products under Development for Mumps, H1 2015 7
Number of Products under Development for Mumps - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Early Stage Products, H1 2015 13
Assessment by Combination Products, H1 2015 22
Number of Products by Top 10 Routes of Administration, H1 2015 23
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 24
Number of Products by Top 10 Molecule Types, H1 2015 25
Number of Products by Stage and Top 10 Molecule Types, H1 2015 26

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2000 View Pricing